-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
-
Summary
-
Emergent BioSolutions Inc. quarterly/annual Nonoperating Income (Expense) history and growth rate from 2010 to 2023.
- Emergent BioSolutions Inc. Nonoperating Income (Expense) for the quarter ending June 30, 2024 was -$66.3M, a 255% decline year-over-year.
- Emergent BioSolutions Inc. Nonoperating Income (Expense) for the twelve months ending June 30, 2024 was -$129M, a 7659% decline year-over-year.
- Emergent BioSolutions Inc. annual Nonoperating Income (Expense) for 2023 was -$4.8M, a 90.2% increase from 2022.
- Emergent BioSolutions Inc. annual Nonoperating Income (Expense) for 2022 was -$49M, a 28.3% decline from 2021.
- Emergent BioSolutions Inc. annual Nonoperating Income (Expense) for 2021 was -$38.2M, a 43.6% decline from 2020.
Nonoperating Income (Expense), Trailing 12 Months (USD)
Nonoperating Income (Expense), Annual (USD)
Nonoperating Income (Expense), YoY Annual Growth (%)